stem cell based gene therapy (LABioMed/Phoenix Nest)

N/A

Report date: 2025/03/20 09:54:37

Base Information

Drug Namestem cell based gene therapy (LABioMed/Phoenix Nest)
Drug Alias Namelentiviral vector expressing alpha-N-acetylglucosaminidase induced neural stem cell therapy (LA Biomed)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapyCell and gene therapy > Cell therapy > Stem cell therapy > Neural stem cell therapy
Mechanisms of ActionAlpha-N-acetylglucosaminidase stimulants
TargetsAlpha-N-acetylglucosaminidase
Therapy Area/IndicationsMucopolysaccharidosis III
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPhoenix Nest Inc
China Registration ClassN/A

Develop Information

Active CompaniesLundquist InstitutePhoenix Nest Inc
Inactive CompaniesN/A
Active IndicationsMucopolysaccharidosis III
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A